气候变化领域集成服务门户(CCPortal): Surgical treatment of pulmonary artery sarcoma: a report of 17 cases

CCPortal

DOI	10.1177/2045894020986394
	Surgical treatment of pulmonary artery sarcoma: a report of 17 cases
	Song W.; Deng L.; Zhu J.; Zheng S.; Wang H.; Song Y.; Liu S.
发表日期	2021
ISSN	20458932
卷号	11 期号:1
英文摘要	Pulmonary artery sarcoma (PAS) is a rare and devastating disease. The diagnosis is often delayed, and optimal treatment remains unclear. The aim of this study is to report our experience in the surgical management of this disease. Between 2000 and 2018, 17 patients underwent operations for PAS at our center. The medical records were retrospectively reviewed to evaluate the clinical characteristics, operative findings, the postoperative outcomes, and the long-term results. The mean age at operation was 46.0 ± 12.4 years (range, 26–79 years), and eight (47.1%) patients were male. Six patients underwent tumor resection alone, whereas the other 11 patients received pulmonary endarterectomy (PEA). There were two perioperative deaths. Follow-up was completed for all patients with a mean duration of 23.5 ± 17.6 months (1–52 months). For all 17 patients, the median postoperative survival was 36 months, and estimated cumulative survival rates at 1, 2, 3, and 4 years were 60.0%, 51.4%, 42.9%, and 21.4%, respectively. The mean survival was 37.0 months after PEA and 14.6 months after tumor resection only (p = 0.046). Patients who had no pulmonary hypertension (PH) postoperatively were associated with improved median survival (48 vs. 5 months, p = 0.023). In conclusion, PAS is often mistaken for chronic pulmonary thromboembolism. The prognosis of this very infrequent disease remains poor. Early detection is essential for prompt and best surgical approach, superior to tumor resection alone, and PEA surgery with PH relieved can provide better chance of survival. © The Author(s) 2021.
英文关键词	pulmonary arteries; pulmonary endarterectomy; pulmonary hypertension; sarcoma; surgical
scopus关键词	warfarin; adult; aged; Article; artificial ventilation; brain metastasis; cancer patient; cancer prognosis; cancer surgery; cancer survival; cardiopulmonary bypass; clinical article; clinical outcome; computer assisted tomography; echocardiography; endarterectomy; female; follow up; general anesthesia; heart arrest; human; lung artery pressure; lung embolism; lung sarcoma; male; median survival time; medical record; middle aged; New York Heart Association class; positron emission tomography; prognosis; pulmonary artery; pulmonary hypertension; retrospective study; surgical approach; survival rate
来源期刊	Pulmonary Circulation
文献类型	期刊论文
条目标识符	http://gcip.llas.ac.cn/handle/2XKMVOVA/177303
作者单位	Department of Cardiac Surgery, FuWai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences Peking Union Medical College, Beijing, China; Department of Cardiac Surgery, Guangdong Cardiovascular Institute, Guangdong Provincial People’s Hospital, Guangdong Academy of Medical Sciences, Guangzhou, China; Department of Radiology, FuWai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences Peking Union Medical College, Beijing, China
推荐引用方式 GB/T 7714	Song W.,Deng L.,Zhu J.,et al. Surgical treatment of pulmonary artery sarcoma: a report of 17 cases[J],2021,11(1).
APA	Song W..,Deng L..,Zhu J..,Zheng S..,Wang H..,...&Liu S..(2021).Surgical treatment of pulmonary artery sarcoma: a report of 17 cases.Pulmonary Circulation,11(1).
MLA	Song W.,et al."Surgical treatment of pulmonary artery sarcoma: a report of 17 cases".Pulmonary Circulation 11.1(2021).